BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36028659)

  • 21. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia.
    Schmidt S; Rainer J; Riml S; Ploner C; Jesacher S; Achmüller C; Presul E; Skvortsov S; Crazzolara R; Fiegl M; Raivio T; Jänne OA; Geley S; Meister B; Kofler R
    Blood; 2006 Mar; 107(5):2061-9. PubMed ID: 16293608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
    Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
    J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
    Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
    Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia.
    Soh SX; Lim JY; Huang JW; Jiang N; Yeoh AE; Ong ST
    PLoS One; 2014; 9(8):e103435. PubMed ID: 25090024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia.
    Bergeron BP; Barnett KR; Bhattarai KR; Mobley RJ; Hansen BS; Brown A; Kodali K; High AA; Jeha S; Pui CH; Peng J; Pruett-Miller SM; Savic D
    bioRxiv; 2023 May; ():. PubMed ID: 36711662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
    Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
    Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid resistance in childhood leukemia.
    Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
    Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
    Nicholson L; Hall AG; Redfern CP; Irving J
    Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.
    Myoumoto A; Nakatani K; Koshimizu TA; Matsubara H; Adachi S; Tsujimoto G
    J Hum Genet; 2007; 52(4):328-333. PubMed ID: 17310274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Geng CD; Vedeckis WV
    Biochemistry; 2010 Oct; 49(41):8892-901. PubMed ID: 20831260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.
    Rainer J; Lelong J; Bindreither D; Mantinger C; Ploner C; Geley S; Kofler R
    Mol Endocrinol; 2012 Jan; 26(1):178-93. PubMed ID: 22074950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
    Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
    Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
    Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
    J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
    Sarno J; Domizi P; Liu Y; Merchant M; Pedersen CB; Jedoui D; Jager A; Nolan GP; Gaipa G; Bendall SC; Bava FA; Davis KL
    Nat Commun; 2023 May; 14(1):2935. PubMed ID: 37217509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational profiling in childhood acute lymphoblastic leukemia: no evidence for glucocorticoid regulation of mRNA translation.
    Aneichyk T; Bindreither D; Mantinger C; Grazio D; Goetsch K; Kofler R; Rainer J
    BMC Genomics; 2013 Dec; 14(1):844. PubMed ID: 24289529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia.
    Jing D; Huang Y; Liu X; Sia KCS; Zhang JC; Tai X; Wang M; Toscan CE; McCalmont H; Evans K; Mayoh C; Poulos RC; Span M; Mi J; Zhang C; Wong JWH; Beck D; Pimanda JE; Lock RB
    Cancer Cell; 2018 Dec; 34(6):906-921.e8. PubMed ID: 30537513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell-type acute lymphoblastic leukemia.
    Sarang Z; Gyurina K; Scholtz B; Kiss C; Szegedi I
    Eur J Haematol; 2016 Nov; 97(5):453-460. PubMed ID: 26947147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
    Hui PY; Chen YH; Qin J; Jiang XH
    Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.